The small molecule Bcl-2/Mcl-1 inhibitor TW-37 shows single-agent cytotoxicity in neuroblastoma cell lines

BACKGROUND: High-risk neuroblastoma with N-Myc amplification remains a therapeutic challenge in paediatric oncology. Antagonism of pro-death Bcl-2 homology (BH) proteins to pro-survival BH members such as Mcl-1 and Bcl-2 has become a treatment approach, but previous studies suggest that a combined i...

Descripción completa

Detalles Bibliográficos
Autores principales: Klenke, Stefanie, Akdeli, Neval, Stelmach, Patrick, Heukamp, Lukas, Schulte, Johannes H., Bachmann, Hagen S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6423774/
https://www.ncbi.nlm.nih.gov/pubmed/30885150
http://dx.doi.org/10.1186/s12885-019-5439-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6423774/
https://www.ncbi.nlm.nih.gov/pubmed/30885150
http://dx.doi.org/10.1186/s12885-019-5439-1

Ejemplares similares